Cynda(SH:603086)2022-08-18 16:00Financial Performance - The company's operating revenue for the first half of 2022 reached ¥1,663,757,427.93, representing a 60.35% increase compared to ¥1,037,610,224.84 in the same period last year[18]. - Net profit attributable to shareholders was ¥197,814,620.49, a significant increase of 233.80% from ¥59,261,649.65 in the previous year[18]. - The net cash flow from operating activities was ¥246,870,494.55, a remarkable turnaround from a negative cash flow of ¥55,362,649.08 in the same period last year, marking a 545.92% improvement[18]. - Basic earnings per share increased to ¥0.64, up 236.84% from ¥0.19 in the same period last year[19]. - The weighted average return on net assets improved to 10.21%, an increase of 6.74 percentage points from 3.47% in the previous year[19]. - The company reported a significant increase in trading financial assets, which reached CNY 324,460,189.59, up 3,601.65% from CNY 8,765,289.60[48]. - The company reported a notable increase in development expenditures to ¥26,607,894.47, up from ¥13,962,518.98, which is an increase of approximately 90.9%[108]. - The company recorded a significant increase in operating profit, which reached ¥216,751,993.82, compared to ¥73,224,800.13 in the first half of 2021[116]. Assets and Liabilities - The total assets of the company increased by 24.67% to ¥3,397,391,683.24 from ¥2,725,106,027.36 at the end of the previous year[18]. - Total liabilities rose to ¥1,410,198,479.27, compared to ¥887,227,964.67, indicating an increase of about 58.9%[109]. - Owner's equity reached ¥1,987,193,203.97, up from ¥1,837,878,062.69, reflecting a growth of approximately 8.1%[109]. - The total current assets increased to CNY 2,270,561,727.34 from CNY 1,668,730,530.62, reflecting a growth of approximately 36%[107]. - The total non-current assets amounted to ¥1,126,829,955.90, compared to ¥1,056,375,496.74, showing a growth of about 6.6%[108]. Research and Development - The company maintains a focus on research and development, collaborating with universities to enhance its innovation capabilities and product development[30]. - Research and development expenses rose to CNY 66,752,561.05, marking a 36.70% increase from CNY 48,831,986.77, reflecting the company's commitment to innovation[44][45]. - The company has established a strong R&D team and increased investment in R&D, leading to the successful market launch of new products such as quikazone[33]. - The company is investing heavily in R&D, with a budget allocation of 200 million RMB for new technology development[85]. Market Position and Strategy - The company is positioned as a leader in the selective herbicide segment, leveraging advantages in technology innovation, quality, scale, and brand[32]. - The company achieved overseas sales of $145 million in the first half of 2022, surpassing the total export amount for the entire year of 2021[40]. - The company has established a comprehensive sales model, including direct sales to domestic agricultural enterprises and both self-operated and indirect exports for international markets[31]. - The company plans to continue focusing on market expansion and new product development to sustain growth in the upcoming quarters[118]. Environmental Responsibility - The company’s pollution prevention facilities operated normally, with wastewater and air emissions meeting standards[61]. - The company has not reported any environmental pollution incidents during the reporting period[61]. - The company has established various environmental protection facilities, including RTO regenerative thermal oxidizers and multiple wastewater treatment technologies, which are operating normally during the reporting period[71]. - The company is committed to reducing carbon emissions and has taken measures to fulfill its environmental responsibilities, although specific details were not disclosed in the report[78]. Shareholder Information - The company distributed cash dividends of 5,547.15 million (including tax) to shareholders, with a payout of 2.50 RMB per 10 shares[93]. - The number of ordinary shareholders reached 15,013 by the end of the reporting period[97]. - The largest shareholder, Wang Xianquan, holds 103,002,099 shares, representing 33.16% of the total shares[99]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties[90]. Financial Reporting and Governance - The company approved the 2021 annual financial report and budget for 2022 during the shareholder meeting[55]. - The company's financial statements were approved by the board of directors on August 18, 2022[144]. - The financial statements are prepared based on the assumption of going concern, in accordance with the relevant accounting standards[149]. - The company has evaluated its ability to continue as a going concern for the next 12 months and found no significant doubts regarding its ability to continue operations[147].